Advisors Capital Management’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTL
Advisors Capital Management's CSTL Position: Q3 2026 in Review
Advisors Capital Management reduced its Castle Biosciences (CSTL) stake by 2.6% in Q3 2026, selling an estimated $190K and leaving 231,920 shares worth $8.24M. The position accounts for 0.08% of the portfolio, ranked #189.
Advisors Capital Management first reported a position in CSTL in Q2 2021 and has held it in 22 quarters since. The position peaked at $9.8M in Q4 2025. 202 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.
- Advisors Capital Management held 231,920 shares of Castle Biosciences worth $8.24M as of Q3 2026.
- Advisors Capital Management sold 6,284 Castle Biosciences shares in Q3 2026, an estimated $190K.
- Castle Biosciences made up 0.08% of Advisors Capital Management's portfolio in Q3 2026, its #189 holding.
- Advisors Capital Management first reported a position in Castle Biosciences in Q2 2021 and has held it in 22 quarters since.
- Advisors Capital Management's Castle Biosciences position peaked at $9.8M in Q4 2025.
- 202 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.
Based on Advisors Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.